Literature DB >> 2603221

Neoadjuvant chemotherapy for localized Ewing's sarcoma of the extremities: preliminary results of a protocol which uses surgery (alone or followed by radiotherapy) for local control.

G Bacci1, D Dallari, D McDonald, M Avella, A Toni, E Barbieri, D Ciaroni, A Sudanese, A Mancini, A Giunti.   

Abstract

From June 1983 to December 1985, thirty-eight patients with localized Ewing's sarcoma of the extremities were treated with a protocol that consisted of an initial nine week period of polychemotherapy (vincristine, adriamycin and cyclophosphamide) followed by local therapy and additional chemotherapy (vincristine, adriamycin, cyclophosphamide and dactinomycin) for one year. As local treatment all patients were offered surgery; thirty-two accepted and six refused. These six patients were locally treated with radiotherapy alone (50 Gy). In the remaining patients an amputation was performed in one case and a resection in thirty-one. In resected patients when a wide margin was achieved (24 cases) no further local treatment was performed; when it was marginal (5 cases) or intralesional (2 cases) radiotherapy at lower doses (40 Gy) followed. At mean follow-up of thirty-seven months the percentage of continuously disease-free patients was 50% for those treated with radiotherapy, 76% with surgery, and 85% with surgery and radiotherapy. Eight patients developed metastatic disease and two patients had local recurrence and metastases. The local recurrences were seen in one patient locally treated with surgery and in one locally treated with radiotherapy. Nine major local complications were observed: three in patients treated with radiotherapy, five in patients treated with surgery, and one in a patient treated with surgery and radiotherapy. These results indicate that after induction chemotherapy conservative surgery is possible in almost all cases of Ewing's sarcoma of the extremities and that such treatment is better than radiotherapy alone as local therapy.

Entities:  

Mesh:

Year:  1989        PMID: 2603221     DOI: 10.1177/030089168907500511

Source DB:  PubMed          Journal:  Tumori        ISSN: 0300-8916


  4 in total

1.  Metastatic extraosseous Ewing's sarcoma (EES)/primitive neuroectodermal tumor (PNET) of the kidney: 8-year durable response after induction and maintenance chemotherapy.

Authors:  Stephen L Richey; Priya Rao; Christopher G Wood; Shreyaskumar Patel; Nizar M Tannir
Journal:  Clin Genitourin Cancer       Date:  2012-04-13       Impact factor: 2.872

2.  Classification of histopathologic changes following chemotherapy in Ewing's sarcoma of bone.

Authors:  H J van der Woude; J L Bloem; A H Taminiau; M A Nooy; P C Hogendoorn
Journal:  Skeletal Radiol       Date:  1994-10       Impact factor: 2.199

3.  Dose-intensified compared with standard chemotherapy for nonmetastatic Ewing sarcoma family of tumors: a Children's Oncology Group Study.

Authors:  Linda Granowetter; Richard Womer; Meenakshi Devidas; Mark Krailo; Chenguang Wang; Mark Bernstein; Neyssa Marina; Patrick Leavey; Mark Gebhardt; John Healey; Robert Cooper Shamberger; Allen Goorin; James Miser; James Meyer; Carola A S Arndt; Scott Sailer; Karen Marcus; Elizabeth Perlman; Paul Dickman; Holcombe E Grier
Journal:  J Clin Oncol       Date:  2009-04-06       Impact factor: 44.544

4.  [Surgery of primary malignant bone tumors].

Authors:  S Flege; M Kuhlen; M Paulussen; S Bielack; H Jürgens
Journal:  Orthopade       Date:  2003-11       Impact factor: 1.087

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.